Author: Karl Pearson
Publisher:
ISBN:
Category : Consumption
Languages : en
Pages : 34

Get Book Here

Book Description

Author: David Heron
Publisher:
ISBN:
Category : Heredity, Human
Languages : en
Pages : 42

Get Book Here

Book Description

Author: Dorothee Heemskerk
Publisher: Springer
ISBN: 3319191322
Category : Medical
Languages : en
Pages : 71

Get Book Here

Book Description
This work contains updated and clinically relevant information about tuberculosis. It is aimed at providing a succinct overview of history and disease epidemiology, clinical presentation and the most recent scientific developments in the field of tuberculosis research, with an emphasis on diagnosis and treatment. It may serve as a practical resource for students, clinicians and researchers who work in the field of infectious diseases.

Author: King K. Holmes
Publisher: World Bank Publications
ISBN: 1464805253
Category : Medical
Languages : en
Pages : 1027

Get Book Here

Book Description
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241565055
Category : Medical
Languages : en
Pages : 204

Get Book Here

Book Description
Chapter 1. Introduction -- chapter 2. Disease burden and 2015 targets assessment -- chapter 3. TB case notifications and treatment outcomes -- chapter 4. Drug-resistant TB -- chapter 5. Diagnostics and laboratory strengthening -- chapter 6. Addressing the co-epidemics of TB and HIV -- chapter 7. Financing -- chapter 8. Research and development -- Annexes.

Author: Amy Barrington
Publisher:
ISBN:
Category : Adaptation (Biology)
Languages : en
Pages : 78

Get Book Here

Book Description

Author: Helen Bynum
Publisher: Oxford University Press
ISBN: 0198727518
Category : Medical
Languages : en
Pages : 349

Get Book Here

Book Description
The story of tuberculosis is a rich and fascinating one. It is a complex and ancient disease that, after many years of virtual disappearance in the developed world, is now making something of a comeback. Helen Bynum tracks the historical development of the disease, and considers the challenges it presents to the modern world.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241563540
Category : Outcome assessment (Medical care)
Languages : en
Pages : 305

Get Book Here

Book Description
WHO's twelfth annual report on global tuberculosis control in a series that started in 1997.

Author: World Health Organization
Publisher:
ISBN: 9789241548168
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
Rev. ed. of: Assessing tuberculosis prevalence through population-based surveys. 2007.

Author: World Health Organization
Publisher:
ISBN: 9789241501583
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly's resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls on Member States to develop a comprehensive framework for the management and care of patients with drug-resistant TB. The recommendations contained in these guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant TB in settings where resources are limited.